Bristol Myers' Sotyktu, a TYK2 inhibitor already approved for psoriasis, scored a win in a Phase III trial for psoriatic ...

Apple plans to roll out an upgraded Siri by spring 2026 as part of iOS 26.4, turning its assistant into something more ...

Berkshire Hathaway, led by investing legend Warren Buffett, holds two dramatically different energy stocks: Occidental ...

Milestone Asset Management slashed its NVIDIA holdings by 21.4% in Q1, reducing its stake to 54,236 shares worth $5.88 ...

Merck’s Animal Health division just fetched a major win as the EU's veterinary committee gave a tail-wagging thumbs-up to ...

AMD unveiled its latest AI arsenal, the Instinct MI350 series, touting 4x more compute and a 35x boost in inference. Despite ...

Sagace Wealth Management LLC more than doubled its holdings in Meta Platforms during Q1, snapping up 816 shares valued at ...

Thermo Fisher is shopping around its microbiology unit, targeting a cool $4 billion from private equity suitors. This move ...

AbbVie has made headlines as a trending stock, though its recent +0.8% gain hasn’t matched broader market leaps. Its earnings ...

Wells Fargo has bumped Microsoft’s price target from $515 to $565, signaling confidence in a software rebound post-summer ...

Netflix stock dipped 2.7% after two board members sold a sizable chunk of shares, shaking investor confidence. Director Jay ...

Tesla shares dipped after renewed political friction threatened a key income stream: zero-emission vehicle credits from ...